IGF1R and cancer: IGF1R inhibitors Picropodophyllin (PPP) and Linsitinib can inhibit autophagy in human triple-negative breast cancer and improve the efficacy of chemotherapy immunotherapy in mice, which is a new strategy for cancer treatment in the context of chemical immunotherapy [46] (Table 1).